ALL-PB:NYE-The Allstate Corporation (USD)

PREFERRED STOCK | |

Last Closing

USD 25.84

Change

0.00 (0.00)%

Market Cap

USD 33.25B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TBB AT&T Inc

+0.02 (+0.09%)

USD 141.28B
PFH Prudential Financial Inc 4.125..

-0.06 (-0.31%)

USD 45.49B
PRS Prudential Financial Inc

-0.03 (-0.12%)

USD 44.13B
SOJC Southern Co

-0.12 (-0.51%)

USD 23.32B
AIO Virtus AllianzGI Artificial In..

-0.15 (-0.69%)

USD 16.20B
AIZN Assurant Inc

-0.35 (-1.67%)

USD 9.38B
RZB Reinsurance Group of America I..

-0.11 (-0.44%)

USD 8.84B
PCG-PA Pacific Gas and Electric Compa..

-0.15 (-0.67%)

USD 6.07B
UNMA Unum Group

-0.18 (-0.70%)

USD 5.67B
PCG-PB Pacific Gas and Electric Compa..

-0.08 (-0.36%)

USD 5.36B

ETFs Containing ALL-PB

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.78% N/A N/A 53% F
Dividend Return 1.27% N/A N/A 36% F
Total Return 4.05% N/A N/A 50% F
Trailing 12 Months  
Capital Gain 3.07% N/A N/A 46% F
Dividend Return 1.27% N/A N/A 17% F
Total Return 4.34% N/A N/A 37% F
Trailing 5 Years  
Capital Gain 0.54% N/A N/A 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.54% N/A N/A 34% F
Average Annual (5 Year Horizon)  
Capital Gain -0.40% N/A N/A 39% F
Dividend Return 0.20% N/A N/A 31% F
Total Return 0.60% N/A N/A 14% F
Risk Return Profile  
Volatility (Standard Deviation) 5.53% N/A N/A 88% B+
Risk Adjusted Return 3.58% N/A N/A 32% F
Market Capitalization 33.25B N/A N/A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike